Effects of physical exercise versus rosiglitazone on endothelial function in coronary artery disease patients with prediabetes

Diabetes, Obesity and Metabolism

Volumn 12, Issue 9, 2010, Pages 825-828

  Desch, S ^a   Sonnabend, M ^a   Niebauer, J ^b   Sixt, S ^c   Sareban, M ^a   Eitel, I ^a   de Waha, S ^a   Thiele, H ^a   Bluh ^a   Schuler, G ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

Author keywords

Clinical trial; Exercise; Glitazones; Thiazolidinediones

Indexed keywords

ROSIGLITAZONE;

ADULT; ARTERY BLOOD FLOW; ARTERY DILATATION; BRACHIAL ARTERY; CARDIOVASCULAR FUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INTRAVASCULAR ULTRASOUND; KINESIOTHERAPY; LETTER; LONG TERM CARE; MALE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

EID: 77955016700     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2010.01234.x     Document Type: Letter

References (12)

1. Mora S, Cook N, Buring JE, Ridker PM, Lee IM. Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms. Circulation 2007, 116:2110-2118. Epub 2007 Oct 22.
2. Hambrecht R, Wolf A, Gielen S. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med 2000, 342:454-460.
3. Walsh JH, Bilsborough W, Maiorana A. Exercise training improves conduit vessel function in patients with coronary artery disease. J Appl Physiol 2003, 95:20-25.
4. Hetzel J, Balletshofer B, Rittig K. Rapid effects of rosiglitazone treatment on endothelial function and inflammatory biomarkers. Arterioscler Thromb Vasc Biol 2005, 25:1804-1809. Epub 2005 Jul 7.
5. Wang TD, Chen WJ, Lin JW, Chen MF, Lee YT. Effects of rosiglitazone on endothelial function, C-reactive protein, and components of the metabolic syndrome in nondiabetic patients with the metabolic syndrome. Am J Cardiol 2004, 93:362-365.
6. Wang TD, Chen WJ, Cheng WC, Lin JW, Chen MF, Lee YT. Relation of improvement in endothelium-dependent flow-mediated vasodilation after rosiglitazone to changes in asymmetric dimethylarginine, endothelin-1, and C-reactive protein in nondiabetic patients with the metabolic syndrome. Am J Cardiol 2006, 98:1057-1062. Epub 2006 Aug 28.
7. Esposito K, Ciotola M, Carleo D. Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome. Diabetes Care 2006, 29:1071-1076.
8. Sixt S, Rastan A, Desch S. Exercise training but not rosiglitazone improves endothelial function in prediabetic patients with coronary disease. Eur J Cardiovasc Prev Rehabil 2008, 15:473-478.
9. Edwards DG, Schofield RS, Lennon SL, Pierce GL, Nichols WW, Braith RW. Effect of exercise training on endothelial function in men with coronary artery disease. Am J Cardiol 2004, 93:617-620.
10. Lavrencic A, Salobir BG, Keber I. Physical training improves flow-mediated dilation in patients with the polymetabolic syndrome. Arterioscler Thromb Vasc Biol 2000, 20:551-555.
11. Sidhu JS, Cowan D, Kaski JC. Effects of rosiglitazone on endothelial function in men with coronary artery disease without diabetes mellitus. Am J Cardiol 2004, 94:151-156.
12. Koh KK. Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability. Cardiovasc Res 2000, 47:648-657.